These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


102 related items for PubMed ID: 3868360

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The reduction of chromium (VI) to chromium (III) by glutathione: an intracellular redox pathway in the metabolism of the carcinogen chromate.
    Wiegand HJ, Ottenwälder H, Bolt HM.
    Toxicology; 1984 Dec; 33(3-4):341-8. PubMed ID: 6515663
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In vivo nephrotoxicity induced in mice by chromium(VI). Involvement of glutathione and chromium(V).
    Hojo Y, Satomi Y.
    Biol Trace Elem Res; 1991 Oct; 31(1):21-31. PubMed ID: 1724173
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The reduction of chromate is a prerequisite of chromium binding to cell nuclei.
    Kortenkamp A, O'Brien P, Beyersmann D.
    Carcinogenesis; 1991 Jun; 12(6):1143-4. PubMed ID: 2044197
    [Abstract] [Full Text] [Related]

  • 7. Contribution to the mechanism of chromate nephrotoxicity in developing rats: EPR investigations.
    Appenroth D, Rost M, Friedrich M, Schulz O.
    Arch Toxicol; 1996 Jun; 71(1-2):25-30. PubMed ID: 9010582
    [Abstract] [Full Text] [Related]

  • 8. Biliary excretion of chromium in the rat: a role of glutathione.
    Norseth T, Alexander J, Aaseth J, Langård S.
    Acta Pharmacol Toxicol (Copenh); 1982 Nov; 51(5):450-5. PubMed ID: 7164826
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Uptake of chromate by rat thymocytes and role of glutathione in its cytoplasmic reduction.
    Debetto P, Arslan P, Antolini M, Luciani S.
    Xenobiotica; 1988 Jun; 18(6):657-64. PubMed ID: 3420944
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Structure and reactivity of a chromium(v) glutathione complex.
    Levina A, Zhang L, Lay PA.
    Inorg Chem; 2003 Feb 10; 42(3):767-84. PubMed ID: 12562191
    [Abstract] [Full Text] [Related]

  • 14. Inhibitory action of hexavalent chromium (Cr(VI)) on the mitochondrial respiration and a possible coupling to the reduction of Cr(VI).
    Ryberg D, Alexander J.
    Biochem Pharmacol; 1984 Aug 01; 33(15):2461-6. PubMed ID: 6466363
    [Abstract] [Full Text] [Related]

  • 15. Chromium(VI)-mediated DNA damage: oxidative pathways resulting in the formation of DNA breaks and abasic sites.
    Casadevall M, da Cruz Fresco P, Kortenkamp A.
    Chem Biol Interact; 1999 Nov 30; 123(2):117-32. PubMed ID: 10597905
    [Abstract] [Full Text] [Related]

  • 16. Effects of vanadium(V) and/or chromium(III) on L-ascorbic acid and glutathione as well as iron, zinc, and copper levels in rat liver and kidney.
    Scibior A, Zaporowska H.
    J Toxicol Environ Health A; 2007 Apr 15; 70(8):696-704. PubMed ID: 17365624
    [Abstract] [Full Text] [Related]

  • 17. A role for molecular oxygen in the formation of DNA damage during the reduction of the carcinogen chromium (VI) by glutathione.
    Kortenkamp A, Casadevall M, Faux SP, Jenner A, Shayer RO, Woodbridge N, O'Brien P.
    Arch Biochem Biophys; 1996 May 15; 329(2):199-207. PubMed ID: 8638952
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.